A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

Por um escritor misterioso

Descrição

medRxiv - The Preprint Server for Health Sciences
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function, Journal of Translational Medicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and prognostic map of COVID-19 - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Mass Spectrometry-Based Proteomics Research to Fight COVID-19: An Expert Review on Hopes and Challenges
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Metabolomics study of COVID-19 patients in four different clinical stages
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
PDF) A time-resolved proteomic and prognostic map of COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning, BMC Medical Informatics and Decision Making
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Frontiers Proteomic Approaches to Unravel Mechanisms of Antibiotic Resistance and Immune Evasion of Bacterial Pathogens
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
IJMS, Free Full-Text
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection - eBioMedicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
IJMS, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)